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Abstract
Background: Current estimates suggest over 218,000 individuals in Australia are chronically infected with hepatitis B
virus. The majority of these people are migrants and refugees born in hepatitis B endemic countries, where attitudes
towards health, levels of education, and English proficiency can be a barrier to accessing the Australian health care
system, and best managing chronic hepatitis B. This study aimed to assess the knowledge of transmission and
consequences of chronic hepatitis B among these patients.
Method: A prospective study was conducted between May and August 2012. Patients with chronic hepatitis B were
recruited from three Royal Melbourne Hospital outpatient clinics. Two questionnaires were administered.
Questionnaire 1, completed during observation of a prospective participants’ consultation, documented information
given to the patient by their clinician. After the consultation, Questionnaire 2 was administered to assess patient
demographics, and overall knowledge of the effect, transmission and treatment of hepatitis B.
Results: 55 participants were recruited. 93% of them were born overseas, 17% used an interpreter, and the average
time since diagnosis was 9.7 years.
Results from Questionnaire 1 showed that the clinician rarely discussed many concepts. Questionnaire 2 exposed
considerable gaps in hepatitis B knowledge. Few participants reported a risk of cirrhosis (11%) or liver cancer (18%).
There was a high awareness of transmission routes, with 89% correctly identifying sexual transmission, 93% infected
blood, and 85% perinatal transmission. However, 25% of participants believed hepatitis B could be spread by sharing
food, and over 50% by kissing and via mosquitoes. A knowledge score out of 12 was assessed for each participant.
The average score was 7.5. Multivariate analysis found higher knowledge scores among those with a family member
also diagnosed with chronic hepatitis B and those routinely seeing the same clinician (p = 0.009 and p = 0.002,
respectively).
Conclusion: This is the largest Australian study assessing knowledge and understanding of the effect, transmission,
and treatment of hepatitis B among chronically infected individuals. The findings highlight the knowledge gaps and
misconceptions held by these patients, and the need to expand education and support initiatives.
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Background
Hepatitis B virus (HBV) is one of the most common
chronic infections affecting up to 350 million people
worldwide [1]. It is the second most important known hu-
man carcinogen after tobacco [1,2] and was estimated to
have resulted in the deaths of 786,000 people in 2010 [3].
The prevalence of chronic hepatitis B (CHB) in
Australia has been estimated at approximately 1% of the
population, affecting over 218,000 individuals in 2011
[4]. The majority of these are migrants from endemic
areas, or Aboriginal and Torres Strait Islander people.
It is estimated that the increasing CHB prevalence in
Australia, predominantly attributable to migration, will re-
sult in a two to three fold increase in premature mortality
from CHB-related liver cancer by 2017 [5,6], with liver
cancer now the fastest increasing cause of cancer deaths
in Australians [7]. Early diagnosis and appropriate man-
agement mitigates negative outcomes, including reducing
the risk of liver cancer [8,9] and reversing cirrhosis [10].
Recent migrants from non- English speaking hepatitis
B endemic countries may have low health literacy [11],
which reduces their capacity to navigate the Australian
health care system and is a barrier to comprehending
concepts such as liver disease, viral transmission, and
antiviral treatment. Combined with fear of stigma, com-
plications and misconceptions, this can be stressful and
debilitating [12] and results in suboptimal management
for the individual and ongoing transmission to suscep-
tible contacts [13].
Improving understanding of hepatitis B in priority
populations and enhancing access to diagnosis and care
are key recommendations of Australia’s Second National
Hepatitis B Strategy 2014-2017 [14]. Regular monitoring
including clinical reviews and appropriate investigations
are essential for all people with CHB [15]. Reducing al-
cohol consumption [16] and smoking cessation also re-
duce progression to advanced liver disease [17], as does
recognition of symptoms associated with disease pro-
gression. Those receiving antiviral treatment need to be
aware of the potentially indefinite duration of treatment,
and that non-adherence allows viral rebound and/or re-
sistance leading to adverse health outcomes [18]. Initia-
tives to improve testing and vaccination for contacts,
and increased monitoring, treatment and educational
options for those infected, are essential for reducing the
burden of CHB [15].
In light of the increasing burden of CHB in Australia,
and the identified need to improve both engagement
with and care delivery for people living with CHB, this
study aimed to understand current patients’ knowledge
and understanding of the transmission, complications
and treatment of CHB, and to investigate factors associ-
ated with the degree of knowledge in these individuals, in
order to guide improvements in clinical and educational




Adult patients with CHB were recruited from three
clinics at the Royal Melbourne Hospital from May to
August 2012. Two of these clinics saw only patients with
a diagnosis of chronic viral hepatitis, and the third clinic
was an immigrant health clinic, seeing a range of infec-
tions. Some patients routinely saw the same physician,
while others were seen by physicians based upon order
of arrival at the clinic. All patients diagnosed with CHB
aged over 18 years were eligible for participation. A sam-
ple size of 50 was determined based on the time avail-
able for the study, the likely number of patients able to
be recruited in this time period, and the number of par-
ticipants required to obtain significant results in a simi-
lar study of patients with latent tuberculosis conducted
at the Royal Melbourne Hospital [19].
Two survey forms were developed and administered
by the one independent researcher (T.D). A piloting
period was conducted and some questions altered prior
to study commencement. Verbal consent was obtained
following an explanation of the study and the entirely
voluntary nature of participation.
Questionnaire 1 recorded information given to partici-
pants during their follow-up consultation, as observed
by the researcher. Questionnaire 2 was administered im-
mediately following the consultation, documenting fac-
tors including age, education, country of birth, and if an
interpreter was used. It also examined patient knowledge
with specific open and closed questions covering transmis-
sion and consequences of CHB, and possible treatment.
The same interpreter (if required) was used during the
consultation and administration of the questionnaire. In-
terviews were conducted by the one researcher to ensure
consistency and accuracy of administration. The question-
naire was read out loud to participants to avoid literacy
bias.
Data analysis
A knowledge score was derived based on the answers to
five questions in Questionnaire 2 reflecting core know-
ledge of CHB to provide an overall score out of 12.
Points were allocated as follows: one point for identify-
ing hepatitis B as their reason for coming to the clinic,
one point for identifying their liver as the affected organ,
and another for an outcome such as cirrhosis, liver dam-
age or HCC in their answer of how HBV can affect the
body. Half a point was awarded for each correct re-
sponse to the ten yes or no questions on how HBV can
be transmitted. When asked the reason for being treated
or not being treated, patients were given one point for
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identifying the lack or presence of liver damage, and one
for mentioning a high or low viral load. Finally, two
points were awarded for identifying either reducing alco-
hol consumption or eating well as factors their doctor
mentioned to improve liver health. Data were analysed
using Stata v10 (College Station, Texas). Univariate ana-
lysis (Wilcoxon rank-sum test and linear regression) was
conducted to detect associations between knowledge
scores and demographic characteristics. Given the large
number of variables assessed relative to sample popula-
tion size, a parsimonious multivariate model was con-
structed, including only those variables that showed
relatively high degrees of association with knowledge
score (in this case those with a p value of less than 0.05
on univariate analysis).
To eliminate any ordinal variation in the model, a for-
wards and backwards stepwise multivariate regression
model was constructed to estimate variables associated
with knowledge score (analysed as a continuous vari-
able). The resulting significance of output was deter-
mined at p ≤ 0.05 with a coefficient produced for each
variable. The coefficient describes a multiplicative factor
relating the knowledge score and socio-demographic
variable; for example, in the case of gender the coeffi-
cient would denote the difference in knowledge score
between females and males. In terms of age, it would de-
note the change in knowledge score per year. All other
data were analysed descriptively.
Ethics
This project was approved by the Melbourne Health Hu-
man Research Ethics Committee as a quality assurance
proposal (approval number QA2012029) and is in com-
pliance with the Helsinki Declaration. All participants
gave informed consent.
Results
Concepts discussed during consultation with clinician
Questionnaire 1 was completed during standard patient
follow-up consultations. No participants were attending
a first appointment, and doctors were not given a stand-
ard script but were observed in their routine practice.
The risks of sexual transmission, blood transmission
and perinatal transmission were discussed in 14.2%, 8%
and 8% of consultations respectively. Vaccination of family
and sexual contacts was also discussed in 17% and 8% of
consultations respectively. Possible life-style changes were
raised including reducing alcohol (31%), smoking cessa-
tion (19%), and weight loss (7%).
Figure 1 Country of birth and HBV endemicity of the study group (n = 55).
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Participants (as assessed via Questionnaire 2)
Of the 58 patients invited to participate, 55 were re-
cruited for the study. Incomplete knowledge data were
collected from four during the piloting period, and these
results were consequently only included in relevant de-
scriptive analyses.
The socio-demographic characteristics of the study
group are shown in Figure 1 and Table 1. The distribu-
tion of countries of birth of the patients is shown in
Figure 1.
Over half (56%) had completed tertiary education with
all but one participant literate in their preferred language.
The participant unable to read in either English or their
preferred language was also the only participant not to
have a family member or friend literate in either language.
Of those not able to read English, all others had an
English-literate family member or friend. The average time
since diagnosis was 9.7 years, with over half having a fam-
ily member or friend also diagnosed with CHB.
Participant knowledge
Questionnaire 2 responses are shown in Table 2.
To assess transmission knowledge, participants were
first asked how HBV could be spread, and then were
asked to answer “yes” or “no” to prompted transmission
options. All but five participants were aware that HBV
could be spread to someone else, with those five being
confused about transmission, some answering “yes” or
“unsure” to all prompted transmission routes offered.
Over half of the participants were receiving treatment
for their CHB, and of these, 55% could name the medi-
cation. 76% were aware that treatment duration would
likely be life-long.
56% of participants indicated they would like to re-
ceive more information. Of those declining more infor-
mation, some stated they already had enough (most
often online), and some just said they did not did want
additional information. Participants not using an inter-
preter were less likely to want more information (53%)
compared to those who used one (70%). Of those wanting
more information the main preferences were for written
or online information both in English and a range of pri-
mary languages.
Anecdotally, many patients were keen to share the
negative impact that hepatitis B had upon their lives,
with one participant saying that it “had destroyed (his)
life”. This is further reflected by the fact that 65% of par-
ticipants were not comfortable discussing their CHB
diagnosis with friends and work colleagues, as well as
the 7% not comfortable telling their family.
Overall knowledge score
The knowledge score represents responses to five ques-
tions that assessed overall knowledge of HBV. The aver-
age knowledge score was 7.5 out of a possible 12 points.
Only one participant answered all questions correctly
with 52% of the study group scoring below 8 and the
lowest score being 2.5.
Univariate analysis correlated 16 participant demo-
graphic variables with participant knowledge scores
(Table 3). All demographic variables that were signifi-
cantly associated with CHB knowledge are marked with
an asterisk. Use of an interpreter and having completed
tertiary education approached significance (p = 0.053 and
p = 0.059 respectively) and were therefore also included
in the multivariate model, as was participant age.
Multivariate analysis
Results of the multivariate analysis are shown in Table 4.
Backwards and forwards step-wise regression suggested
that having a family member with CHB and having seen
the same clinician more than once were associated with
a better knowledge score.
Discussion
A limited number of studies have been conducted into
the knowledge of people living with CHB regarding their
condition [20-22]. This is the largest Australian study to
investigate knowledge of CHB among patients attending
specialist outpatient clinics. The majority of study partic-
ipants (93%) were born overseas (62% from Asia, 22%
Table 1 Profile of the study group (N = 55)
Study group characteristics No. % of cohort
Gender Male 37 67
Female 18 33




in Australia n = 51)
< 2 years 0 0
2-5 years 9 18
5-10 Years 19 37
>10 Years 23 45
Lived in a refugee camp Yes 14 25
No 41 75
Educational level Primary 4 7
Secondary 20 37
Tertiary 31 56





English Literacy Yes 42 76
No 13 24
Preferred language literacy Yes 54 98
No 1 2
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from Africa, 7% from Europe and 9% from Oceania) and
had a family member also diagnosed with CHB. This val-
idates observations that the predominant burden of
CHB is experienced by migrants from endemic countries
where perinatal and early childhood acquisition is com-
mon, resulting in multiple affected family members. It
also emphasises the cultural diversity seen among indi-
viduals with CHB, and the consequential accommoda-
tion required by the health system [23]. Knowledge of
the effects and risks associated with CHB was low in
Table 2 Participant responses to Questionnaire 2 assessing
HBV knowledge (N = 48)
Knowledge questions Answer No. %
Why are you coming to
this clinic?
Hepatitis B 43 78
Hepatitis 3 5
Other (incorrect/unsure) 9 16
What causes hepatitis B? Concept of Virus 19 44
Concept of something
attacking liver/infection
3 7N = 43- Significant prompting†
Incorrect 4 9
Unsure 17 40
How can hepatitis B affect
your body?
Affects the liver 36 65
Jaundice 2 4
Fatigue 5 9
Multiple answers allowed Asymptomatic 7 13
Liver damage, cirrhosis 6 11









How can hepatitis Be
spread to someone else?
Sexual transmission 27 49
Blood contact 35 64
Unprompted‡
Multiple answers possible Needle contamination 7 13
Perinatal 9 16
Medical contamination 5 9






Sharing food 41 75
Sexual Contact 49 89
Contact with infected blood 51 93
Kissing 26 47
From mother to child
during birth
45 82
Unclean needles 48 87
Breathing 44 80
Mosquitoes 23 42
Blood transfusion 50 91
Unclean medical equipment 47 85
Why are you being
treated/starting treatment
for Hepatitis B? N = 31




Mentioned both 2 7
Unsure/Incorrect 8 26
Table 2 Participant responses to Questionnaire 2 assessing
HBV knowledge (N = 48) (Continued)
Those on treatment
N = 29 (53% of cohort)
Correctly named medication 16 55
Indefinite antiviral course 22 76
Never skip dose 21 72
Do you know why you are
not being treated for
Hepatitis B?
N = 24 (44% of cohort)
Mentioned virus 8 33
Mentioned liver damage 2 8
Mentioned both 2 8
Unsure/Incorrect 10 42
Other 2 8
Is there anything you can do
to improve your Hepatitis B?
Multiple answers allowed N = 51
Yes 43 84
Reduce alcohol 24 47
Stop smoking 7 14
Lose weight/exercise 10 20
Treatment 5 10










Do you feel comfortable




Do you usually understand




Do you think the





Other medical conditions Yes 36 65
No 19 35
†This question was not answered correctly during the piloting period,
therefore these participants were not included in the results for this question.
All the other participants received significant prompting such as: “What is
hepatitis B in your body? Is it a germ, or microbe, or something else?” The
results of this question were not included in the knowledge assessment, as
the question was often misunderstood and therefore appears not to be a
good assessment of knowledge.
‡For transmission questions, patients were first asked if HBV could be spread
to someone else, and if yes, how it could be spread. They were then
prompted as to whether HBV can be spread by sharing food, sexual
intercourse, and so on.
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Table 3 Univariate analysis of associations between knowledge scores and demographic characteristics of the study cohort
Sociodemographic characteristics No. (%) Median knowledge score Interquartile range p-value
Gender Male 35 (67) 7.5 5-8.8 0.0268**
Female 16 (33) 8 7.75-9.5
Interpreter used None 42 (82) 8 6-9
Trained 5 (9) 7 3-8 0.059
Family/Friend 4 (8) 7.75 5.25-9.25 0.69
English Literacy Yes 39 (76) 6.8 4.25-8 0.045**
No 12 (24) 8 6-9.5
Lived in a refugee camp Yes 13(25) 8 7-8.5 0.63
No 38 (75) 7.5 5.5-9
Time in Australia Continuous - 0.65
<2 years 0
2-5 years 8 (16) 7.25 5.25-9.5
5-10 Years 19 (35) 7.5 6-9.5 0.97
>10 Years 24 (49) 8 7.25-8.75 0.79
Educational level Primary 4 (8) 5.75 3.75-8.25
Secondary 19 (37) 7.5 5-8.5 0.48
Tertiary 13 (25) 8 7.5-9.5 0.05**
Tertiary + 15 (29) 8 6-10 0.14
Clinic Public hepatitis 22 8 5.5-9
Immigrant and refugee 7 7 4.5-8 0.34
Privatised hepatitis 22 7.5 6-9.5 0.24
Time since diagnosis < 1 year 3 (6) 5.5 5-7.5
2-5 18 (35) 7.5 6-8 0.45
6-15 17 (33) 8 6-10
>16 13 (25) 8 7-9 0.22
Country diagnosed Australia 41 (80) 7.5 5.5-8.5 0.19
Other 10 (20) 8.5 6.5-10.5
Seen clinician previously n = 44 Yes 27 (61) 8 7-9.5 0.010**
No 17 (39) 6 4.5-8
No. of years seeing clinician 0.003**
Know anyone else with HBV No-one 24 (47) 7.3 5.25-8
Family 20 (39) 8.3 7.75-9.5 0.007**
Friends 3 (6) 8 4.5-10
Both 2 (4) 6.3 4.5-8 0.73
Not specified 2 (4) 5.8 4-7.5
Family comfortable Yes 47(92) 7.8 6-8.75 0.94
No 4(8) 8 6-9
Friend comfortable Yes 32(63) 8 7.25-9.25 0.049**
No 19(37) 4.5-8
Age Continuous 0.21
Under 30 11 8 6-10
30-45 21 8 7-9 0.75
46-60 11 7.5 6-9.5 0.96
61 and over 8 6.8 4.75-8.25 0.19
**Significant at ≤ 0.05.
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over half the participants, and there were major miscon-
ceptions regarding HBV transmission. There was signifi-
cantly higher knowledge among individuals with a family
member also diagnosed with CHB, and among patients
routinely seeing the same doctor.
Important knowledge gaps were identified, for ex-
ample, the majority of participants lacked understanding
about the sequelae of CHB beyond its effect on the liver,
with one answering that it affected the lungs. Although
CHB is often asymptomatic, complications can occur,
and patients should be aware of symptoms that could in-
dicate progressive disease. Our findings contrast with a
Malaysian study [24] where participants had a greater
knowledge of symptoms such as jaundice and fatigue
(55% and 54% respectively). However, unlike the present
study, which used both open and closed questioning, the
Malaysian study used only prompted yes/no questions,
potentially limiting the comparability of these results.
The majority (89%) of participants were aware that
HBV can be sexually transmitted, which is higher than
the 79-80% reported in previous studies [24,25]. More-
over, whereas only 6.8% of participants in the Malaysian
study [24] knew that HBV was not spread by sharing
food, 75% of patients questioned in the present study
were aware of this. That HBV can be spread by sharing
food and eating utensils is a common misconception, es-
pecially among Asian communities, where hepatitis A
prevention strategies were promoted following outbreaks
in China in 1988 [26]. As hepatitis A is spread via the
faecal-oral route, prevention strategies included not
sharing food or eating utensils, and this has since been
confused with HBV transmission routes.
Over half of participants in our study believed HBV
could be spread via kissing or mosquito bites, and 20%
by breathing. Such misconceptions have been found by
similar studies in other countries [27-31]. These miscon-
ceptions can have very deep and negative impacts on
those affected, constituting an unnecessary and prevent-
able burden. Dispelling these misconceptions is import-
ant for improving the quality of life of those infected
[32,33], and increasing awareness in the general com-
munity to reduce the stigma that arises from lack of
knowledge.
Only four participants showed an understanding of the
virus’s effect on the liver and how this related to their
treatment status. During consultations terms such as
viral load, and viral activity were commonly used, but
we do not know if they were always understood by
participants.
Some participants showed a passive approach towards
their health, deferring to their doctor’s advice as their
reason for treatment and appointment attendance. Pas-
sivity towards health has been correlated with low health
literacy [34] and highlights the need for patient engage-
ment as well as education, and this is particularly pertin-
ent among recently arrived migrants who may have
many competing priorities. It is important to note that
the group interviewed represents those engaged with the
healthcare system and attending specialist appointments.
There are many individuals with CHB not engaged with
the healthcare system, and more than 100,000 Australians
estimated to be living with undiagnosed CHB [4], whose
health literacy may be even lower.
The results of Questionnaire 1 suggest that patients
are generally not provided with detailed information
during ongoing monitoring of CHB. However, it is clear
that some participants would benefit from repetition of
important transmission and management information.
While it could be assumed all participants were provided
with extensive information upon diagnosis, it is possible
that long-term retention of this information is not uni-
versal. Therefore, assumptions of knowledge may not be
valid, irrespective of whether the cause is never having
been provided with the information, or not recalling it.
Better knowledge was seen among those with a family
member also diagnosed with CHB, possibly by providing
a direct source of information following diagnosis. Hav-
ing a relative with the same condition, especially if they
have suffered the sequelae of liver dysfunction, may also
promote communication, engagement, support and en-
couragement for regular monitoring [33]. Discussing the
diagnosis with people sharing cultural and linguistic ties
may also be conducive to better knowledge, although
this could also be a source of the many myths regarding
CHB infection [12]. Community-outreach programs
based on providing culturally and linguistically salient
information have been internationally recognised for ef-
fectively disseminating information among Hispanic/
Latino communities in the United States [35].
Seeing the same the doctor has been shown to im-
prove patient knowledge and management of chronic
conditions such as asthma [35]. Our results validate this
as positive associations with knowledge score were ob-
served among patients having seen the clinician before
Table 4 Multivariate regression model of variables






Know both family and
friends diagnosed with HBV
−3.26 −6.96-0.42 0.081







R2 = 0.42 (i.e. 42% of the variability seen within the knowledge score is explained
by this model).
**Significant at ≤ 0.05.
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(p = 0.02) and with increasing years seeing the same clin-
ician (p = 0.003). A possible explanation is that with return
visits, the treating clinician can incrementally educate the
patient and reinforce previous discussions although more
research in this area is needed. It also provides consistency
and familiarity for the patient. This should be incorporated
into clinical practice aimed at improving patient engage-
ment with the healthcare system and reducing the number
of patients lost to follow up.
During the study period, between 9%-31% of patients
failed to attend their appointments (all clinic patients ra-
ther than only those with CHB). This provides an indica-
tion of the difficulty of monitoring and maintaining
contact with patients who experience language barriers
and may change residential address frequently. Wu et al
[25] cited inconvenience as a significant barrier to
healthcare access among 40% of participants with CHB,
with after-hour clinics having higher attendance rates.
The clinics in our study operated from 9 am-12.30 pm
sometimes with considerable delays in seeing patients.
The finding that the majority of patients stated that they
did not feel comfortable disclosing the infection to their
friends and colleagues highlights the potential difficulty
of attending appointments during business hours.
This study had several limitations. As recruitment was
from clinics based in a major Victorian hospital, it does
not provide information about patients from other set-
tings such as general practice or rural clinics. Our study
group may also have had a slight bias towards those not
using an interpreter, as on two occasions the interpreter
was not able to complete the interview, preventing those
patients from participating. Furthermore, patients at-
tending these clinics are already engaged with the
healthcare system, and may not be representative of the
general population living with hepatitis B.
Patient acceptance of the research was high, with 55 of
58 invited agreeing to participate. However, with a num-
ber of variables assessed for impact on knowledge score,
and considered for inclusion in multivariate analysis, this
analysis may have lacked power to detect some factors
truly associated with knowledge score (type II error).
Conclusion
As HBV prevalence and attributable liver cancer inci-
dence increases in Australia and other developed coun-
tries, health service provisions for people with CHB will
need to improve and expand, and should involve educa-
tion and support for those chronically infected and their
families. There are many HBV patient resources, both
online and in print, available in a number of priority lan-
guages (for example www.hepbhelp.org.au). Liaison nurses
and community self-management programs also exist to
support and educate this group. These resources are cur-
rently underused and it was one intention of this research
to provide results that challenge clinicians to aim for im-
proved engagement and continued education of this pa-
tient group, especially for long-term patients. These
results also highlight the need to educate patients regard-
ing common misconceptions in addition to actual trans-
mission routes. A better understanding of CHB will
improve compliance and monitoring and may reduce the
significant morbidity, anxiety and stress surrounding CHB
infection.
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